YasarTorres-YaghiMD

Neurology • Washington, DC

Movement Disorder, Dementia & Geriatrics

Director of the Parkinsonism and Dementia Clinic

Join to view full profile

Dr. Torres-Yaghi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Torres-Yaghi's full profile

Already have an account?

Office
3800 Reservoir Rd Nw
Department Of Neurology
Washington, DC 20007
Phone+1 202-444-2000
Is this information wrong?

Education & Training

MedStar Health/Georgetown University HospitalResidency, Neurology, 2012 - 2015
MedStar Health (Baltimore)Internship, Internal Medicine, 2011 - 2012
George Washington University School of Medicine and Health SciencesClass of 2011

Certifications & Licensure

VA State Medical License 2012 - 2024
DC State Medical License 2015 - 2024
MD State Medical License 2015 - 2023
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.
Fernando L Pagan, Paul E Schulz, Yasar Torres-Yaghi, Gregory M Pontone> ;CNS Drugs. 2024 May 1
1 citations
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease.
Stuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, Fabrizio Stocchi, Angelo Antonini> ;Parkinsonism & Related Disorders. 2023 Sep 1
Correction to: Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
Rajesh Pahwa, Stuart H Isaacson, Gary W Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh> ;Neurology and Therapy. 2023 Oct 1
Istradefylline effects on tremor dominance (TD) and postural instability and gait difficulty (PIGD).
Nobutaka Hattori, Olivier Rascol, Yu Nakajima, Shelby M King, Akihisa Mori, Torres-Yaghi, Y., Pagan, F.> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
Adenosine Aantagonists and Parkinson's disease.
Michelle Offit, Brian Nagle, Gonul Ozay, Irma Zhang, Yasar Torres-Yaghi, Fernando Pagan, Anastassia Kerasidis> ;International Review of Neurobiology. 2023 Jan 1
2 citations
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
Rajesh Pahwa, Stuart H Isaacson, Gary W Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh> ;Neurology and Therapy. 2022 Dec 1
1 citations
Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis.
Marwan Sabbagh, Gary W Small, Stuart H Isaacson, Yasar Torres-Yaghi, Fernando Pagan, Rajesh Pahwa> ;International Journal of Psychiatry in Clinical Practice. 2023 Mar 1
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic.
Shadi Ghourchian, Yasar A Torres-Yaghi, Stuart H Isaacson, Fernando Pagan, Kelly E Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa> ;Telemedicine Journal and e-Health. 2022 Mar 17
6 citations
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
Fernando L Pagan, Yasar Torres-Yaghi, Michaeline L Hebron, Barbara Wilmarth, R Scott Turner, Sara Matar, Dalila Ferrante, Jaeil Ahn, Charbel Moussa> ;Alzheimer's & Dementia. 2022 Jan 1
8 citations
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson's Disease: A PMD Alliance Survey.
Neal Hermanowicz, Maria Cristina Ospina, Yasar Torres-Yaghi, Sherrie Gould, Kelly Papesh, Jason A Rivera, Susan Miller, Sarah Jones, Kelli Musick, Damian May> ;Neuropsychiatric Disease and Treatment. 2022 Jan 1
11 citations
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease.
Alan J. Fowler, Jaeil Ahn, Michaeline Hebron, Timothy L Chiu, Reem Ayoub, Sanjana Mulki, Habtom W. Ressom, Yasar Torres-Yaghi, Barbara Wilmarth, Fernando Pagan, Charbe...> ;Neurology. Genetics. 2021 Nov 12
Erratum to: Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.
Alan J. Fowler, Michaeline Hebron, Kaluvu Balaraman, Wangke Shi, Alexander A Missner, Jonathan D Greenzaid, Timothy L Chiu, Clementina Ullman, Ethan Weatherdon, Val Du...> ;Human Molecular Genetics. 2021 Jun 17
3 citations
Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson...
Islam Fayed, Kelsey Cobourn, Gnel Pivazyan, Yasar Torres-Yaghi, Fernando Pagan, Steven E. Lo, Allen S. Mandir, Christopher G. Kalhorn> ;Journal of Clinical Neuroscience. 2021 Jan 18
4 citations
QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.
Yasar Torres-Yaghi, Amelia Carwin, Jacob Carolan, Steven Nakano, Fahd Amjad, Fernando Pagan> ;Neuropsychiatric Disease and Treatment. 2021 Jan 1
30 citations
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
Fernando Pagan, Barbara Wilmarth, Yasar Torres-Yaghi, Michaeline Hebron, Sanjana Mulki, Dalila Ferrante, Sara Matar, Jaeil Ahn, Charbel Moussa> ;Movement Disorders. 2021 Mar 1
16 citations
Sialorrhea in Parkinson’s Disease
Jonathan Isaacson, Sanskruti Patel, Yasar Torres-Yaghi, Fernando Pagan> ;Toxins. 2020 Oct 31
23 citations
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases
Greenzaid, J., Alan J. Fowler, Michaeline Hebron, Kaluvu Balaraman, Wangke Shi, Alexander A Missner, Jonathan D Greenzaid, Timothy L Chiu, Clementina Ullman, Ethan Wea...> ;Human Molecular Genetics. 2020 Oct 10
64 citations
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
Raymond Scott Turner, Michaeline Hebron, Abigail Lawler, Elizabeth E. Mundel, Nadia Yusuf, J. Nathan Starr, Muhammad Anjum, Fernando Pagan, Yasar Torres-Yaghi, Wangke ...> ;Annals of Neurology. 2020 May 28
101 citations
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Fernando Pagan, Michaeline Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Elizabeth E. Mundel, Nadia Yusuf, Nathan J. Starr, Muhammad Anjum, Joy Arellan...> ;JAMA Neurology. 2020 Mar 1
64 citations
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Fernando Pagan, Michaeline Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Elizabeth E. Mundel, Nadia Yusuf, Nathan J. Starr, Joy Arellano, Helen H. Howa...> ;Pharmacology Research & Perspectives. 2019 Apr 1
8 citations
Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings.
Bethany Peterson, Melissa J. Armstrong, Douglas Galasko, James E. Galvin, Jennifer G. Goldman, David J. Irwin, Henry L. Paulson, Daniel I. Kaufer, James B. Leverenz, A...> ;Alzheimer's Research & Therapy. 2019 Mar 13
1 citations
Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.
Abigail Lawler, Yasar Torres-Yaghi, Fahd Amjad, Charbel Moussa, Fernando Pagan> ;Neurology. Clinical Practice. 2018 Jun 1
9 citations
The diagnosis and natural history of Huntington disease.
Fernando Pagan, Yasar Torres-Yaghi, Marcelle Altshuler> ;Handbook of Clinical Neurology. 2017 Jan 1
175 citations
Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
Fernando Pagan, Michaeline Hebron, Ellen H. Valadez, Yasar Torres-Yaghi, Xu Huang, Reversa Mills, Barbara Wilmarth, Hellen Howard, Connell Dunn, Alexis Carlson, Abigai...> ;Journal of Parkinson's Disease. 2016 Jan 1
8 citations
Cardiac Cephalgia
Yasar Torres-Yaghi, Justin Salerian, Carrie Dougherty> ;Current Pain and Headache Reports. 2015 Apr 1
Join now to see all